Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study

Alzheimer's disease (AD) is the most common type of dementia, with increasing prevalence and no disease-modifying treatment available yet. There is increasing evidence—from interventions targeting mitochondria—that may shed some light on new strategies for the treatment of AD. Previously, using...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanova, Natalia A., Ershov, Nikita I., Kolosova, Nataliya G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664545/
https://www.ncbi.nlm.nih.gov/pubmed/31396299
http://dx.doi.org/10.1155/2019/3984906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664545/
https://www.ncbi.nlm.nih.gov/pubmed/31396299
http://dx.doi.org/10.1155/2019/3984906

Ejemplares similares